| 000 | 03038nam a22004695i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-58811-2 | ||
| 003 | DE-He213 | ||
| 005 | 20251030112608.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240702s2024 sz | s |||| 0|eng d | ||
| 020 |
_a9783031588112 _9978-3-031-58811-2 |
||
| 024 | 7 |
_a10.1007/978-3-031-58811-2 _2doi |
|
| 050 | 4 | _aRE1-994 | |
| 072 | 7 |
_aMJQ _2bicssc |
|
| 072 | 7 |
_aMED063000 _2bisacsh |
|
| 072 | 7 |
_aMJQ _2thema |
|
| 100 | 1 |
_aWeiss, Jeffrey N. _eauthor. _4aut _4http://id.loc.gov/vocabulary/relators/aut _979862 |
|
| 245 | 1 | 0 |
_aAlzheimer's Disease and the Eye _h[electronic resource] / _cby Jeffrey N. Weiss. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aCham : _bSpringer Nature Switzerland : _bImprint: Springer, _c2024. |
|
| 300 |
_aX, 139 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aPart 1: Introduction -- Chapter 1. Alzheimer's Disease -- Chapter 2. Rates of Dementia -- Chapter 3. Biomarkers and Clinical Endpoints -- Chapter 4. Ocular Biomarkers -- Part 2: Diagnosis -- Chapter 5. Biochemical and Neuroimaging -- Chapter 6. Cognitive Decline -- Chapter 7. EEG/ERP -- Chapter 8. Eye Tracking -- Chapter 9. Light Intervention -- Chapter 10. Retina -- Chapter 11. Tears -- Chapter 12. Telemedicine -- Chapter 13. Virtual Reality -- Part 3: Treatment -- Chapter 14. Recruiting Trials in the US -- Chapter 15. Not Yet Recruiting Trials in the US. | |
| 520 | _aThis book is a compendium of the worldwide studies of Alzheimer’s disease utilizing the eye as a biomarker, or as a treatment method, that are registered with the United States National Institutes of Health website, clinicaltrials.gov. Clinicaltrials.gov is the largest listing of research studies in the world. The study titles are provided, as is the country of origin and the Clinical Trial Number in order to make it easier for the reader to locate the study and obtain further information. New drug development is costly and time consuming. If through the use of biomarkers, study durations and research costs decrease, there is a greater possibility of a new and effective drug to treat this devastating disease. The eye offers the possibility of early diagnosis and of treatment. Alzheimer’s Disease and the Eye is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers. | ||
| 650 | 0 |
_aOphthalmology. _972072 |
|
| 650 | 1 | 4 |
_aOphthalmology. _972072 |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031588105 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031588129 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031588136 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-031-58811-2 |
| 912 | _aZDB-2-SME | ||
| 912 | _aZDB-2-SXM | ||
| 999 |
_c61258 _d61258 |
||